NCT04176133 - Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions

Healthy

Interventions

DRUG

Entolimod

Intramuscular (IM) single dose administration. Entolimod is provided as a sterile, clear, colorless or slightly yellow liquid for IM injection.

DRUG

Placebo

Intramuscular (IM) single dose administration, no active ingredient. A matching placebo is provided as a sterile, clear, colorless to slightly yellow liquid for IM injection in prefilled vials that are identical in appearance to the vials containing active drug.

DRUG

Influenza vaccine

Intramuscular (IM) single dose administration. Fluzone, high-dose split virion influenza virus vaccine, Sanofi Pasteur

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester